Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Race Oncology Ltd. ( (AU:RAC) ) has issued an update.
Racura Oncology Ltd has applied for quotation on the ASX of 470,501 new fully paid ordinary shares, following the exercise or conversion of existing options or other convertible securities. The additional share quotation modestly increases the company’s listed capital base, potentially enhancing liquidity for shareholders and reflecting ongoing utilisation of equity-linked incentives or financing structures without signaling a major change in strategic direction.
The most recent analyst rating on (AU:RAC) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Race Oncology Ltd. stock, see the AU:RAC Stock Forecast page.
More about Race Oncology Ltd.
Racura Oncology Ltd (ASX: RAC) is a biotechnology company operating in the oncology sector, focused on developing cancer therapies and related pharmaceutical products for the healthcare market.
Average Trading Volume: 245,179
Technical Sentiment Signal: Buy
Current Market Cap: A$551.7M
For an in-depth examination of RAC stock, go to TipRanks’ Overview page.